Entera Bio (ENTX) Share-based Compensation (QoQ) (2021 - 2026)
Entera Bio (ENTX) Share-based Compensation (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Entera Bio | 186.78 Mn | 182.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.35% |
| Dec 31, 2025 | -23.41% |
| Sep 30, 2025 | 82.12% |
| Jun 30, 2025 | -15.73% |
| Mar 31, 2025 | 6.71% |
| Dec 31, 2024 | -39.01% |
| Sep 30, 2024 | 55.18% |
| Jun 30, 2024 | 28.88% |
| Mar 31, 2024 | 45.91% |
| Dec 31, 2023 | -16.97% |
| Sep 30, 2023 | -18.86% |
| Jun 30, 2023 | -8.53% |
| Mar 31, 2023 | 8.18% |
| Dec 31, 2022 | 333.64% |
| Sep 30, 2022 | -84.20% |
| Jun 30, 2022 | -27.80% |
| Mar 31, 2022 | 161.96% |
| Dec 31, 2021 | -41.40% |
| Sep 30, 2021 | 0.80% |
| Jun 30, 2021 | 90.52% |